A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate

NCT02052375 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis
Pharmacokinetics of ASP2408

Interventions

DRUG: ASP2408
DRUG: Placebo

Sponsor

Astellas Pharma Global Development, Inc.